Developmental neuroscience

Unlocking the Genius of Autism -New School Opens in Riverhead

Retrieved on: 
Friday, June 11, 2021
Branches of biology, Psychiatric diagnosis, Psychiatry, Neuroscience, Learning disabilities, Autism, Autism spectrum, Developmental neuroscience, Developmental psychology

RIVERHEAD, N.Y., June 11, 2021 /PRNewswire/ --Acton Academy Eastern Long Island today announced the first phase of the Autism Studio launching July 6, 2021 in Riverhead, NY.

Key Points: 
  • RIVERHEAD, N.Y., June 11, 2021 /PRNewswire/ --Acton Academy Eastern Long Island today announced the first phase of the Autism Studio launching July 6, 2021 in Riverhead, NY.
  • It is a revolutionary new program that seeks to unlock this highly intelligent, grossly misunderstood population.
  • The Autism Studio, phase one, will begin this July, inviting non-speaking and minimally-speaking autistic individuals to learn S2C.
  • Andrea has published two books on autism, Autism A New Humanity (Hay House 2015) and Autism: A New Perspective (KDP 2019) which she co-authored with a non-verbal autist from Portugal.

Cabaletta Bio to Present at the Jefferies Healthcare Conference

Retrieved on: 
Thursday, May 27, 2021
Branches of biology, Developmental neuroscience, Biology, Clinical medicine, Autoimmunity, Immunology, Myasthenia gravis, MuSK protein

A live webcast of the fireside chat will be available on the News and Events section of the companys website at www.cabalettabio.com .

Key Points: 
  • A live webcast of the fireside chat will be available on the News and Events section of the companys website at www.cabalettabio.com .
  • Following the presentation, a replay of the webcast will be available on the website for 90 days.
  • Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases.
  • The Companys lead preclinical product candidate, MuSK-CAART, is in IND-enabling studies and is designed as a potential treatment for patients with MuSK-associated myasthenia gravis.

Shine Behavioral Academy Opens For K-6 Students On The Autism Spectrum

Retrieved on: 
Monday, May 10, 2021
Mind, Self, Psychology, Behaviorism, Psychological theories, Autism, Autism spectrum, Developmental neuroscience, Psychiatric diagnosis, Applied behavior analysis

b'ARLINGTON, Texas, May 10, 2021 /PRNewswire/ --Filling a serious gap for underserved DFW-area kids on the autism spectrum, Shine Behavioral Academy opens its doors to its first students in Arlington on May 10.

Key Points: 
  • b'ARLINGTON, Texas, May 10, 2021 /PRNewswire/ --Filling a serious gap for underserved DFW-area kids on the autism spectrum, Shine Behavioral Academy opens its doors to its first students in Arlington on May 10.
  • The tuition-based, nonprofit school will provide behaviorally centered K-6 education with a curriculum based on leading-edge research and applied behavioral analysis.\nThe concept for Shine Behavioral Academy was born from the parents and staff of Shine Behavioral, an Applied Behavioral Analytics (ABA) multidisciplinary center that opened in 2017.
  • For information on programs, tuition and enrollment, please go to www.shinebehavioral.academy .\nFounded in Arlington, Texas, in 2021, Shine Behavioral Academy is a 501(c)3 nonprofit, tuition-based private school offering customized learning for K-6 students on the autism spectrum.
  • The concept for Shine Behavioral Academy was born from the parents and staff of Shine Behavioral LLC.

Rangam and Spectrum Fusion Collaboration Empowers Neurodivergent Employees and Job Seekers to Jumpstart their Careers During Autism Acceptance Month

Retrieved on: 
Thursday, April 29, 2021
Articles, Autism, Branches of biology, Developmental neuroscience, Developmental psychology, Psychiatric diagnosis, Autism spectrum, ZX Spectrum, Spectrum, JumpStart, Neuroscience

SourceAbled uses an end-to-end, tech-enable hiring program to build a connected inclusive community in the workplace for neurodivergent talent.

Key Points: 
  • SourceAbled uses an end-to-end, tech-enable hiring program to build a connected inclusive community in the workplace for neurodivergent talent.
  • "One of our goals is employment for all, but too often talent on the autism spectrum is overlooked for creative positions.
  • The exemplary work the Spectrum Fusion team has produced showcases that individuals on the spectrum can excel in virtually any field when given the opportunity.
  • To learn more about Spectrum Fusion, visit www.spectrumfusion.org .\nView original content to download multimedia: http://www.prnewswire.com/news-releases/rangam-and-spectrum-fusion-colla...\n'

New Center for Children with Autism Opens Next Week

Retrieved on: 
Tuesday, April 20, 2021
Psychiatric diagnosis, Branches of biology, Autism, Psychiatry, Abnormal psychology, Learning disabilities, Autism spectrum, Developmental neuroscience, Developmental psychology, Global perceptions of autism, Centro Ponceño de Autismo

b'WARRENVILLE, Ill., April 20, 2021 /PRNewswire/ -- Caravel Autism Health will open the doors to a new autism therapy center serving families across the Naperville/Warrenville/Aurora area next week.

Key Points: 
  • b'WARRENVILLE, Ill., April 20, 2021 /PRNewswire/ -- Caravel Autism Health will open the doors to a new autism therapy center serving families across the Naperville/Warrenville/Aurora area next week.
  • "Our team specializes in Applied Behavior Analysis (ABA) therapy, which helps children develop skills, create connections, and gain confidence.
  • "\nIn addition to evaluation, diagnostics and treatment, Caravel Autism Health also provides support, counseling, and guidance for families impacted by autism.
  • Caravel\'s team of autism health experts specializes in the evaluation, diagnosis and treatment of children on the autism spectrum.

Therapeutic Solutions International Spin-Off Campbell Neurosciences Identifies Mechanism of Action for Umbilical Cord Blood Derived NarcoStem™ Drug Rehabilitation Product

Retrieved on: 
Monday, April 19, 2021
Branches of biology, Developmental neuroscience, Growth factors, Neurotrophic factors, Peptide hormones, Brain-derived neurotrophic factor, Immunotherapy

This is not something that ketamine, CBD, or psilocybin are capable of doing.

Key Points: 
  • This is not something that ketamine, CBD, or psilocybin are capable of doing.
  • Demonstration that BDNF mediates therapeutic activities of NarcoStem helps accelerate the timeline for clinical translation of this inhalable therapeutic.
  • Unfortunately, it is almost impossible to provide recombinant BDNF directly into the brain due to its size and half live.
  • "\nTherapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases.

License and Commercialization agreement between Pierre Fabre and ValenzaBio on an anti-IGF-1R antibody for the development of a novel treatment in Thyroid Eye Disease (TED)

Retrieved on: 
Thursday, April 8, 2021
Branches of biology, Biology, Medical specialties, Immunology, Developmental neuroscience, Insulin-like growth factor 1, Monoclonal antibody, Pierre Fabre, Fabre

In parallel, Pierre Fabre is pursuing the development of its anti-IGF-1R ADC program (W0101) in oncology.

Key Points: 
  • In parallel, Pierre Fabre is pursuing the development of its anti-IGF-1R ADC program (W0101) in oncology.
  • Based on these properties, this monoclonal antibody has the potential to be the best in class product for the treatment of TED.
  • ValenzaBio has demonstrated an ability to apply thoughtful clinical and regulatory strategies to take oncology drugs into autoimmune and inflammatory settings.
  • Pierre Fabre is 86%-owned by the Pierre Fabre Foundation, a government-recognized public-interest foundation, and secondarily by its own employees through an international employee stock ownership plan.

Gemiini Promoting The Shift From Awareness To Acceptance

Retrieved on: 
Wednesday, April 7, 2021
Autism, Branches of biology, Psychiatric diagnosis, Abnormal psychology, Disability, Autism spectrum, Developmental neuroscience, World Autism Awareness Day, Autism rights movement, Societal and cultural aspects of autism

SPOKANE, Wash., April 7, 2021 /PRNewswire/ -- Gemiini is celebrating Acceptance Month, a movement among advocacy organizations to increase understanding, acceptance, and support for people with autism.

Key Points: 
  • SPOKANE, Wash., April 7, 2021 /PRNewswire/ -- Gemiini is celebrating Acceptance Month, a movement among advocacy organizations to increase understanding, acceptance, and support for people with autism.
  • The original 2008 United Nations mandate for a "World Autism Awareness Day" undergoing a cultural shift.
  • As part of the growing recognition of the gifts and capacities that autistic individuals bring to our society, Gemiini has joined the movement to designate April as "Autistic Acceptance Month."
  • "Gemiini is committed to promoting acceptance ofpeople with autism into our social fabric through personalized therapies that increase speech, language, reading, life skills, and social skills," said Bryan Davey, Chief Executive Officer for Gemiini.

Cabaletta Bio to Present at the 20th Annual Needham Healthcare Conference

Retrieved on: 
Wednesday, April 7, 2021
Branches of biology, Developmental neuroscience, Biology, Clinical medicine, Autoimmunity, Immunology, Myasthenia gravis, MuSK protein

A live webcast of the fireside chat will be available on the News and Events section of the companys website at www.cabalettabio.com .

Key Points: 
  • A live webcast of the fireside chat will be available on the News and Events section of the companys website at www.cabalettabio.com .
  • Following the presentation, a replay of the webcast will be available on the website for 90 days.
  • Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases.
  • The Companys lead preclinical product candidate, MuSK-CAART, is in IND-enabling studies and is designed as a potential treatment for patients with MuSK-associated myasthenia gravis.

HumanN Launches New SuperBeets® Memory & Focus Chews to Support Brain Health

Retrieved on: 
Thursday, March 25, 2021
Branches of biology, Developmental neuroscience, Growth factors, Neurotrophic factors, Peptide hormones, Neurochemistry, Brain-derived neurotrophic factor, Brain, Resveratrol

SuperBeetsMemory & Focus is a unique supplement that contains clinically-studied polyphenol compounds to support two aspects of brain health: brain blood flow and BDNF.

Key Points: 
  • SuperBeetsMemory & Focus is a unique supplement that contains clinically-studied polyphenol compounds to support two aspects of brain health: brain blood flow and BDNF.
  • Blood flow to the brain, along with Brain-Derived Neurotrophic Factor (BDNF) - a key protein found in the brain - are important in promoting overall cognitive health.
  • SuperBeetsMemory & Focus features a highly pure form of Resveratrol produced through a unique fermentation process, along with a patented coffee fruit extract that have been clinically shown to help promote brain blood flow and support brain health, respectively.
  • Humann'sfull catalog of products, including the new SuperBeets Memory & Focus Chews is available online and on Amazon.